~~<i id='1932DC3B5D'><strike id='1932DC3B5D'><tt id='1932DC3B5D'><pre id='1932DC3B5D'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：comprehensive 2025-10-08 15:29:27 Page View：4433

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Adam's Biotech Scorecard: Do Sarepta's exon
Next article： Apple is now the first public company to be valued at $3 trillion

leisure time

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

iTeos Therapeutics debuts first data on TIGIT

AdobeITeosTherapeuticsofferedthefirstlookatclinicaldataforitsexperimentalcancerantibodythatworksbybl

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Heat waves linked to early deliveries, preterm births in new study

RebeccaNoble/GettyImagesHeatwavesarebecomingmorefrequentandmoreintense,posingmoreofahealthriskaround

WSS

hotspot

hotspot

explore

leisure time

Heat waves linked to early deliveries, preterm births in new study